LivaNova PLC

Healthcare · Medical Devices

77.20$ -1.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

LivaNova PLC (LIVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 391 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LIVN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	295	311	285	321	310	278	250	288	272	297	251	277	269	288	242	182	240	270	248	264	253	270	240	254	253	275	263	294	286	310	295	319	318	322	317	353	358	361	362	391	1,472
Cost of Revenue	106	147	101	111	110	106	88	94	98	93	87	80	89	83	72	66	97	118	84	92	85	73	72	70	82	91	89	89	84	120	88	104	93	102	96	114	113	121	117	117	468
Gross Profit	189	164	184	211	200	172	162	194	174	204	164	197	179	205	171	116	143	151	163	172	169	198	168	184	171	184	174	205	202	190	207	215	225	219	221	239	245	240	245	274	1,003
Research & Development	32	28	30	43	31	33	32	34	42	38	44	35	46	26	27	25	47	44	45	53	42	44	41	34	36	45	50	51	47	46	46	45	49	43	38	47	49	52	49	54	203
Selling, General & Administrative	109	11	87	94	97	101	104	123	115	122	126	127	123	131	120	98	99	110	110	123	109	124	119	116	115	120	124	126	135	133	130	129	132	136	134	138	139	143	144	158	584
Total Operating Expenses	152	164	153	175	165	143	145	167	167	169	179	171	180	167	147	132	146	403	169	209	152	177	159	153	303	170	176	188	197	278	191	175	190	182	172	185	191	197	193	224	805
Operating Income	23	-37	-19	31	32	18	13	22	-5.8	-277	-21	-30	26	-144	23	-15	-3.2	-252	-5.7	-36	16	21	9.5	32	-132	14	-2.3	17	4.5	-88	16	40	36	37	49	54	54	43	52	50	198
Interest Expense	3.5	4.0	2.3	1.6	1.4	2.5	2.1	3.0	2.6	2.1	1.7	4.1	4.8	4.4	4.8	5.7	15	16	16	17	11	6.3	7.8	14	13	13	13	15	15	16	16	16	16	16	15	12	11	20	8.3	7.2	46
Pre-Tax Income	21	-36	20	66	31	7.9	22	19	-8.9	-279	-21	-36	21	-150	-6.1	-22	-19	-265	-28	-53	-42	-6.5	5.5	19	-106	6.4	9.7	5.3	-2.0	-94	-34	22	44	56	-316	33	34	28	27	19	107
Income Tax Expense	9.7	-9.8	5.7	3.3	1.9	39	3.9	-1.0	-2.7	-70	-6.6	-6.2	-11	-6.7	-45	66	-4.0	19	2.6	3.9	1.9	2.1	2.5	2.5	1.3	4.7	2.4	4.1	5.3	-111	7.7	5.2	12	0.6	12	6.2	7.1	-3.2	4.3	-90	-82
Net Income	-1.6	-30	11	47	28	-112	13	15	-7.2	-211	-15	-29	32	-143	38	-88	-15	-284	-31	-56	-43	-8.6	3.0	16	-107	1.7	7.4	1.2	-7.3	16	-42	16	33	56	-327	27	27	31	22	109	189
EBITDA	60	-11	52	61	56	19	41	46	11	-260	-3.0	-8.2	48	48	16	3.4	18	-42	16	-20	-14	17	28	48	-80	35	38	35	28	-63	-5.2	49	73	85	-286	61	57	47	51	26	181

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings